Company Logo

Lebrikizumab

Agricultural Biotechnology

Updated on May 8, 2020

View more like this | Visit SHIRLEY, NY | Contact Bella Smith
Image for Lebrikizumab with ID of: 4211233
Recombinant monoclonal antibody to IL13. Lebrikizumab (INN) is a humanized monoclonal antibody and an experimental immunosuppresive drug for the treatment of asthma that cannot be adequately controlled with inhalable glucocorticoids.
goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.